R&D
Health Innovators Jennifer Schranz

Health Innovators – Jennifer Schranz

In the rare and ultra-rare disease space, the paucity of both data and patients makes everything about research and development more complicated.

R&D
Health Innovators Cytokinetics

Health Innovators – Fady Malik and Steve Heitner

In this instalment of Health Innovators, EiC Jonah Comstock sits down virtually with Fady Malik, EVP of research and development at Cytokinetics and Steve Heitner, the company’s VP of clinical rese

Digital
Reuters Pharma USA Maria Whitman

Reuters Pharma USA – Maria Whitman

At Reuters Pharma USA in March, ZS Associates' Maria Whitman sat down with pharmaphorum to discuss why it's time to reinvent pharma's marketing strategy

Sales & Marketing

Sales & Marketing
Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Digital

Market Access

Editor's Picks

  1. NICE finally backs Enhertu for HER2-low breast cancer
  2. Novo Nordisk rebrands as Novo as new CEO charts turnaround
  3. MPs seek probe into UK-US pharma deal's impact on NHS
  4. FDA unveils framework for its expedited IND pilot
  5. WCLC: Lung cancer news from BioNTech, Akeso, and Roche

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more